BIOC Past Earnings image   This BIOC past earnings page last updated 4/20/2023
BIOC Past Earnings
PeriodPast Earnings DateGAAP
Q4 20224/17/2023-1.090
Q3 202211/21/2022-0.330
Q1 20225/23/2022-0.160
Q4 20214/6/2022-0.180
Q3 202111/15/20210.030
Q2 20218/16/2021-0.140
Q1 20215/12/20210.190
Q4 20203/29/20210.140
Q3 202011/12/2020-0.430
Q2 20208/12/2020-0.500
Q1 20205/13/2020-1.100
Q4 20193/25/2020-2.000
Q3 201911/13/2019-2.500
Q2 20198/12/2019-3.800
Q1 20195/8/2019-6.100
Q4 20183/28/2019-14.300
Q3 201811/13/2018-24.200
Q2 20188/14/2018-27.000
Q1 20185/15/2018-33.000
Q4 20173/28/2018-54.000
Q3 201711/9/2017-60.000
Q2 20178/10/2017-63.000
Q1 20175/11/2017-63.000
Q4 20163/7/2017-81.000
Q3 201611/9/2016-513.000
Q2 20168/2/2016-180.000
Q1 20165/12/2016-225.000
Q4 20153/9/2016-216.000
Q3 201511/5/2015-216.000
Q2 20158/10/2015-198.000
Q1 20155/12/2015-333.000
Q4 20143/9/2015-783.000
Q3 201411/13/2014-783.000
Q2 20148/8/2014-603.000
Q1 20142/6/2014-1764.000
Q4 201312/31/2013-16533.000
Q4 20122/5/201390.000
Q3 201211/12/2012-603.000
Q2 20128/8/201254.000
BIOC Past Revenue
PeriodPast Earnings DateGAAP
Q4 20224/17/2023-0.01B
Q3 202211/21/20220.01B
Q1 20225/23/20220.02B
Q4 20214/6/20220.01B
Q3 202111/15/20210.02B
Q2 20218/16/20210.01B
Q1 20215/12/20210.02B
Q4 20203/29/20210.02B
Q3 202011/12/20200.01B
Q2 20208/12/20200.00B
Q1 20205/13/20200.00B
Q4 20193/25/20200.00B
Q3 201911/13/20190.00B
Q2 20198/12/20190.00B
Q1 20195/8/20190.00B
Q4 20183/28/2019859526
Q3 201811/13/2018761591
Q2 20188/14/2018822238
Q1 20185/15/2018806943
Q4 20173/28/2018995226
Q3 201711/9/20171.11M
Q2 20178/10/20171.28M
Q1 20175/11/20171.68M
Q4 20163/7/20171.29M
Q3 201611/9/20161.05M
Q2 20168/2/2016662860
Q1 20165/12/2016221369
Q4 20153/9/2016218283
Q3 201511/5/2015164856
Q2 20158/10/201576768
Q1 20155/12/2015150000
Q4 20143/9/20150.08M
Q3 201411/13/20140.01M
Q2 20148/8/20140.02M
Q1 20142/6/20140.03M
Q4 201312/31/20130.02M
Q4 20122/5/20130.03M
Q3 201211/12/20120.02M
Q2 20128/8/20120.02M
Quotes delayed 20 minutes

Email EnvelopeFree BIOC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocept (BIOC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BIOL Past Earnings
BIOR Past Earnings
BIVI Past Earnings
BKD Past Earnings
BLCM Past Earnings
BLFS Past Earnings
BLI Past Earnings
BLPH Past Earnings
BLUE Past Earnings
BMEA Past Earnings

BIOC Past Earnings Q&A

What was the best and worst BIOC past earnings results?
For Biocept, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest BIOC past earnings result in our data set was 90.000/share posted in Q4 2012, while the lowest was in Q4 2013 when BIOC posted -16533.000/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when BIOC reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q4 2022 at -0.01B of revenue.

  Suggested answer: There are 39 BIOC past earnings results in our data set.

On this page we presented the BIOC past earnings date information for Biocept. Reviewing that BIOC Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2012, when BIOC posted gaap of 90.000/share. Meanwhile the lowest BIOC past earnings result was in Q4 2013, when BIOC posted gaap of -16533.000/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when BIOC reported 0.02B in revenue, while the smallest revenue quarter was Q4 2022 when BIOC reported -0.01B in revenue.

Any self directed investor doing their due diligence on BIOC or any other given stock can benefit from researching all of the Biocept past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Biocept past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BIOC. Thanks for visiting, and the next time you need to research BIOC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: FRLA Average Annual Return, IMUX shares outstanding history, Funds Holding DBU.

 

BIOC Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.